您的位置:首页 > 推荐期刊 > 期刊详情
推荐期刊
Clinical lung cancer
分享到:

影响因子:2.038

ISSN:1525-7304

出版社:Elsevier

出版地:New York

出版国家:United States

刊期:双月刊

创刊时间:1999

语种:英文

审稿周期:较慢,6-12周

中科院分区:4

投稿命中率:命中率约30.90%较易

国外数据收录:IMIM

中国收录文章数:36

5年影响因子:2.312

研究领域:肺肿瘤

官方链接:http://www.sciencedirect.com/science/journal/152573...

投稿须知:http://www.sciencedirect.com/science/journal/152573...

期刊介绍:

Clinical Lung Cancer is the world’s premier peer-reviewed, tumor-specific, clinical oncology devoted to publishing clinically relevant articles on detection, diagnosis, prevention, and treatment of lung cancer. Indexed in Index Medicus/Medline/Pubmed, ISI (Current Contents/Clinical Medicine, Science Citation Index Expanded (Web of Science), Journal Citation Reports), EMBASE, CINAHL, and Chemical Abstracts. Each issue of Clinical Lung Cancer features peer–reviewed original contributions‚ invited comprehensive reviews‚ and current treatment reports‚ as well as "Meeting Highlights" reports taken from major oncology meetings each year. Also included are brief editorials of current news and the latest topics concerning lung cancer for the clinician.

同领域期刊名称 影响因子

维普投稿-SCI专栏论文服务由广州品恒信息科技有限公司独立运营并承担相应的责任与义务

友情链接:维普网 | 维普投稿平台 | 维普论文检测 | 维普论文选题